Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 – Entering an Era of Sustained Growth and Further Advancing Its Medical…

Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline  Business Wire

See the rest here:

Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical...

Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with…

Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric Dermatology  The Manila Times

See the original post:

Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with...

The 70th Annual Theodore H. Stanley Update in Anesthesiology: A Premier Educational and Networking Event – University of Utah School of Medicine

The 70th Annual Theodore H. Stanley Update in Anesthesiology: A Premier Educational and Networking Event  University of Utah School of Medicine

See the article here:

The 70th Annual Theodore H. Stanley Update in Anesthesiology: A Premier Educational and Networking Event - University of Utah School of Medicine